Adverse events216

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 216

Type	Event	Organ system	Group	Affected	At risk
other	Anaemia	Blood and lymphatic system disorders	Dabrafenib in Combination With Trametinib (On-treatment Period)	21	40
other	Anaemia	Blood and lymphatic system disorders	Dabrafenib in Combination With Trametinib (Post-treatment Follow-up Phase)	0	16
other	Leukopenia	Blood and lymphatic system disorders	Dabrafenib in Combination With Trametinib (On-treatment Period)	2	40
other	Leukopenia	Blood and lymphatic system disorders	Dabrafenib in Combination With Trametinib (Post-treatment Follow-up Phase)	0	16
other	Sinus tachycardia	Cardiac disorders	Dabrafenib in Combination With Trametinib (On-treatment Period)	3	40
other	Sinus tachycardia	Cardiac disorders	Dabrafenib in Combination With Trametinib (Post-treatment Follow-up Phase)	0	16
other	Supraventricular tachycardia	Cardiac disorders	Dabrafenib in Combination With Trametinib (On-treatment Period)	2	40
other	Supraventricular tachycardia	Cardiac disorders	Dabrafenib in Combination With Trametinib (Post-treatment Follow-up Phase)	0	16
other	Ventricular extrasystoles	Cardiac disorders	Dabrafenib in Combination With Trametinib (On-treatment Period)	3	40
other	Ventricular extrasystoles	Cardiac disorders	Dabrafenib in Combination With Trametinib (Post-treatment Follow-up Phase)	0	16
other	Cataract	Eye disorders	Dabrafenib in Combination With Trametinib (On-treatment Period)	4	40
other	Cataract	Eye disorders	Dabrafenib in Combination With Trametinib (Post-treatment Follow-up Phase)	0	16
other	Dry eye	Eye disorders	Dabrafenib in Combination With Trametinib (On-treatment Period)	2	40
other	Dry eye	Eye disorders	Dabrafenib in Combination With Trametinib (Post-treatment Follow-up Phase)	0	16
other	Optic disc haemorrhage	Eye disorders	Dabrafenib in Combination With Trametinib (On-treatment Period)	2	40
other	Optic disc haemorrhage	Eye disorders	Dabrafenib in Combination With Trametinib (Post-treatment Follow-up Phase)	0	16
other	Visual field defect	Eye disorders	Dabrafenib in Combination With Trametinib (On-treatment Period)	2	40
other	Visual field defect	Eye disorders	Dabrafenib in Combination With Trametinib (Post-treatment Follow-up Phase)	0	16
other	Abdominal discomfort	Gastrointestinal disorders	Dabrafenib in Combination With Trametinib (On-treatment Period)	2	40
other	Abdominal discomfort	Gastrointestinal disorders	Dabrafenib in Combination With Trametinib (Post-treatment Follow-up Phase)	0	16

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04452877/events

API reference For AI assistants

Adverse events216

Sources 3

Read this list from software.